Human Cytokine-Induced Memory-Like Natural Killer Cells

Journal of Innate Immunity

Volumn 7, Issue 6, 2015, Pages 563-571

  Berrien Elliott, Melissa M ^a   Wagner, Julia A ^a   Fehniger, Todd A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine; Cytokine receptor; IL 12; IL 15; IL 18; Immunotherapy; Innate memory; Natural killer cells

Indexed keywords

CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; HAPTEN;

ADOPTIVE IMMUNOTHERAPY; CANCER IMMUNOTHERAPY; CYTOKINE INDUCED KILLER CELL; CYTOKINE INDUCED MEMORY LIKE NATURAL KILLER CELL; CYTOKINE PRODUCTION; EFFECTOR CELL; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; MEMORY CELL; NATURAL KILLER CELL; NONHUMAN; POINT OF CARE TESTING; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; ANIMAL; CELLULAR IMMUNITY; HEMATOLOGIC DISEASE; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MOUSE; PATHOLOGY; VIRUS INFECTION;

ANIMALS; CYTOKINES; HAPTENS; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; KILLER CELLS, NATURAL; MICE; VIRUS DISEASES;

EID: 84945446776     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000382019     Document Type: Review

References (62)

1. Janeway CA Jr, Medzhitov R: Innate immune recognition. Annu Rev Immunol 2002; 20: 197-216.
2. Mogensen TH: Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 2009; 22: 240-273.
3. Cooper MD, Alder MN: The evolution of adaptive immune systems. Cell 2006; 124: 815-822.
4. Vitetta ES, Berton MT, Burger C, Kepron M, Lee WT, Yin XM: Memory B and T cells. Annu Rev Immunol 1991; 9: 193-217.
5. Farber DL, Yudanin NA, Restifo NP: Human memory T cells: generation, compartmentalization and homeostasis. Nat Rev Immunol 2014; 14: 24-35.
6. Kim C, Williams MA: Nature and nurture: Tcell receptor-dependent and T-cell receptorindependent differentiation cues in the selection of the memory T-cell pool. Immunology 2010; 131: 310-317.
7. Caligiuri MA: Human natural killer cells. Blood 2008; 112: 461-469.
8. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S: Functions of natural killer cells. Nat Immunol 2008; 9: 503-510.
9. Di Santo JP: Natural killer cells: diversity in search of a niche. Nat Immunol 2008; 9: 473-475.
10. Vidal SM, Khakoo SI, Biron CA: Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience. Curr Opin Virol 2011; 1: 497-512.
11. Orr MT, Lanier LL: Natural killer cell education and tolerance. Cell 2010; 142: 847-856.
12. Orange JS: Formation and function of the lytic NK-cell immunological synapse. Nat Rev Immunol 2008; 8: 713-725.
13. Freud AG, Caligiuri MA: Human natural killer cell development. Immunol Rev 2006; 214: 56-72.
14. Yu J, Freud AG, Caligiuri MA: Location and cellular stages of natural killer cell development. Trends Immunol 2013; 34: 573-582.
15. Long EO, Sik Kim H, Liu D, Peterson ME, Rajagopalan S: Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol 2013; 31: 227-258.
16. Lanier LL: NK cell receptors. Annu Rev Immunol 1998; 16: 359-393.
17. Maria A De, Bozzano F, Cantoni C, Moretta L: Revisiting human natural killer cell subset function revealed cytolytic CD56 dim CD16+ NK cells as rapid producers of abundant IFN-? on activation. Proc Natl Acad Sci U S A 2011; 108: 728-732.
18. Fauriat C, Long EO, Ljunggren H, Bryceson YT: Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 2010; 115: 2167-2176.
19. Cooper MA, Fehniger TA, Caligiuri MA: The biology of human natural killer-cell subsets. Trends Immunol 2001; 22: 633-640.
20. Romee R, Leong JW, Fehniger TA: Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer. Scientifica (Cairo) 2014; 2014: 205796.
21. Lopez-Verges S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, Pircher H, et al: CD57 defines a functionally distinct population of mature NK cells in the human CD56 dim CD16+ NK-cell subset. Blood 2010; 116: 3865-3874.
22. Yu J, Mao HC, Wei M, Hughes T, Zhang J, Park I, et al: CD94 surface density identifies a functional intermediary between the CD56 bright and CD56 dim human NK-cell subsets. Blood 2010; 115: 274-281.
23. Bjorkstrom NK, Riese P, Heuts F, Andersson S, Fauriat C, Ivarsson MA, et al: Expression patterns of NKG2A, KIR, and CD57 define a process of CD56 dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010; 116: 3853-3864.
24. Chan A, Hong D, Atzberger A, Filer AD, Buckley CD, Mcmichael A, et al: CD56 bright human NK cells differentiate into CD56 dim cells: role of contact with peripheral fibroblasts. J Immumol 2013; 179: 89-94.
25. Mace EM, Hsu AP, Monaco-Shawver L, Makedonas G, Rosen JB, Dropulic L, et al: Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56 bright subset. Blood 2013; 121: 2669-2677.
26. Min-Oo G, Kamimura Y, Hendricks DW, Nabekura T, Lanier LL: Natural killer cells: walking three paths down memory lane. Trends Immunol 2013; 34: 251-258.
27. O'Leary JG, Goodarzi M, Drayton DL, Yu H, von Andrian UH: T cell-and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 2006; 7: 507-516.
28. Paust S, Gill HS, Wang B-Z, Flynn MP, Moseman EA, Senman B, et al: Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol 2010; 11: 1127-1135.
29. Sun JC, Beilke JN, Lanier LL: Adaptive immune features of natural killer cells. Nature 2009; 457: 557-561.
30. Sun JC, Madera S, Bezman NA, Beilke JN, Kaplan MH, Lanier LL: Proinflammatory cytokine signaling required for the generation of natural killer cell memory. J Exp Med 2012; 209: 947-954.
31. Foley B, Cooley S, Verneris MR, Pitt M, Curtsinger J, Luo X, et al: Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood 2012; 119: 2665-2674.
32. Guma M, Angulo A, Vilches C, Gomez-lozano N, Malats N, Lopez-Botet M: Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004; 104: 3664-3671.
33. Guma M, Budt M, Saez A, Brckalo T, Hengel H, Angulo A, et al: Expansion of CD94/ NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2006; 107: 3624-3631.
34. Bjorkstrom NK, Lindgren T, Stoltz M, Fauriat C, Braun M, Evander M, et al: Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med 2011; 208: 13-21.
35. Petitdemange C, Becquart P, Wauquier N, Beziat V, Debre P, Leroy EM, et al: Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog 2011; 7:e1002268.
36. Foley B, Cooley S, Verneris MR, Curtsinger J, Luo X, Waller EK, et al: Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen. J Immunol 2012; 189: 5082-5088.
37. Rolle A, Pollmann J, Ewen E, Le VT, et al: IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion. J Clin Invest 2014; 124: 5305-5316.
38. Cooper MA, Elliott JM, Keyel PA, Yang L, Carrero JA, Yokoyama WM: Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci U S A 2009; 106: 1915-1919.
39. Keppel M, Yang L, Cooper M: Murine NK cell intrinsic cytokine-induced memory-like responses are maintained following homeostatic proliferation. J Immumol 2013; 190: 4754-4762.
40. Ni J, Miller M, Stojanovic A, Garbi N, Cerwenka A: Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. J Exp Med 2012; 209: 2351-2365.
41. Romee R, Schneider SE, Leong JW, Chase JM, Keppel CR, Sullivan RP, et al: Cytokine activation induces human memory-like NK cells. Blood 2012; 120: 4751-4760.
42. Leong JW, Chase JM, Romee R, Schneider SE, Sullivan RP, Cooper MA, et al: Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells. Biol Blood Marrow Transpl 2014; 20: 463-473.
43. Waldmann TA: The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol 2006; 6: 595-601.
44. Malek TR: The biology of interleukin-2. Ann Rev Immunol 2008; 26: 453-479.
45. Fehniger TA, Cooper MA, Nuovo GJ, Cella M, Facchetti F, Colonna M, et al: CD56 bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: A potential new link between adaptive and innate immunity. Blood 2003; 101: 3052-3057.
46. Rosario M, Romee R, Schneider S, Wagner J, Berrien-Elliott M, Leong J, et al: Human cytokine-induced memory-like NK cells are active against myeloid leukemia in vitro and in vivo. Blood 2014; 124:A1117.
47. Farag SS, Fehniger TA, Ruggeri L, Velardi A, Caligiuri MA: Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 2002; 100: 1935-1947.
48. Ljunggren HG, Malmberg KJ: Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol 2007; 7: 329-339.
49. Wu J, Lanier LL: Natural killer cells and cancer. Adv Cancer Res 2003; 90: 127-156.
50. Velardi A, Ruggeri L, Mancusi A, Aversa F, Christiansen FT: Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: A tool for immunotherapy of leukemia. Curr Opin Immunol 2009; 21: 525-530.
51. Hsu KC, Dupont B: Natural killer cell receptors: regulating innate immune responses to hematologic malignancy. Semin Hematol 2005; 42: 91-103.
52. Olson JA, Leveson-Gower DB, Gill S, Baker J, Beilhack A, Negrin RS: NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects. Blood 2010; 115: 4293-4301.
53. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, et al: Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097-2100.
54. Cooley S, Trachtenberg E, Bergemann TL, Saeteurn K, Klein J, Le CT, et al: Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. Blood 2009; 113: 726-732.
55. Venstrom JM, Pittari G, Gooley TA, Chewning JH, Spellman S, Haagenson M, et al: HLAC-dependent prevention of leukemia relapse by donor activating KIR2DS1. N Engl J Med 2012; 367: 805-816.
56. Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK, et al: Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 2005; 105: 3051-3057.
57. Rubnitz JE, Inaba H, Ribeiro RC, Pounds S, Rooney B, Bell T, et al: NKAML: A pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia. J Clin Oncol 2010; 28: 955-959.
58. Leong J, Chase J, Romee R, Schneider S, Sullivan R, Fehniger T: Cytokine activation induces CD25 expression and a functional highaffinity IL-2 receptor on CD56 dim human NK cells. J Immunol 2014; 190: 183.10. http:// jimmunol.org/cgi/content/meeting- abstract/190/1-MeetingAbstracts/183.10.
59. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song Y-J, Yang L, et al: Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005; 436: 709-713.
60. Luetke-Eversloh M, Hammer Q, Durek P, Nordstrom K, Gasparoni G, Pink M, et al: Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog 2014; 10: e1004441.
61. Schlums H, Cichocki F, Tesi B, Theorell J, Beziat V, Holmes TD, et al: Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity 2015; 42: 443-456.
62. Lee J, Zhang T, Hwang I, Kim A, Nitschke L, Kim M, et al: Epigenetic modification and antibody-dependent expansion of memorylike NK cells in human cytomegalovirus-infected individuals. Immunity 2015; 42: 431-442.